180 results on '"Sugimoto, Tohru"'
Search Results
2. Supplementary Figure S2 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
3. Data from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
4. Supplementary Figure S1 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
5. Data from Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity
6. Data from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
7. Supplementary Table 1 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
8. Data from Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity
9. Supplementary Figure S1 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
10. Supplementary Table 1 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
11. Supplementary Data from Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity
12. Supplementary Figure S2 from Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
13. Supplementary Table and 3 Figures from Methylation-Associated Silencing of the Nuclear Receptor 1I2 Gene in Advanced-Type Neuroblastomas, Identified by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification
14. Supplementary Table and 3 Figures from Methylation-Associated Silencing of the Nuclear Receptor 1I2 Gene in Advanced-Type Neuroblastomas, Identified by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification
15. Quantum chemical calculation of intrinsic reaction coordinates from trans to cis structure of fluvoxamine
16. A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients
17. Ab-initio study of pyrrole ring deformation in the indole group of 5-HT interacting with water molecules
18. Rare MYC-amplified Neuroblastoma With Large Cell Histology
19. Development of rhabdomyolysis in a child after norovirus gastroenteritis
20. Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
21. Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis
22. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST)
23. Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS
24. Boron neutron capture therapy as new treatment for clear cell sarcoma: Trial on different animal model
25. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines
26. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model
27. Is the prognosis of stage 4s neuroblastoma in patients 12months of age and older really excellent?
28. Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2
29. Prenatal and lactational exposure to low-doses of bisphenol A alters adult mice behavior
30. Preoperative analysis of 11q loss using circulating tumor-released DNA in serum: A novel diagnostic tool for therapy stratification of neuroblastoma
31. Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression
32. Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV
33. 3C1024 Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2(3C Protein: Funcrion 2,The 49th Annual Meeting of the Biophysical Society of Japan)
34. Prenatal and lactational exposure to low-doses of bisphenol A alters brain monoamine concentration in adult mice
35. Abstract 4842: Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas
36. Lysosomal-Associated Protein Multispanning Transmembrane 5 Gene (LAPTM5) Is Associated with Spontaneous Regression of Neuroblastomas
37. Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice
38. Treatment for Leigh syndrome by monitoring dichloroacetate concentration
39. A novel PAX3 rearrangement in embryonal rhabdomyosarcoma
40. 1P-205 Theoretical study of photoisomerization of fluvoxamine(Neuroscience & Sensory systems, The 47th Annual Meeting of the Biophysical Society of Japan)
41. Circulating Methylated-DCR2Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients withMYCNNonamplified Neuroblastoma
42. Low-dose Protracted Irinotecan as a Palliative Chemotherapy for Advanced Neuroblastoma
43. Fiber-Tracking Techniques Can Predict the Degree of Neurologic Impairment for Periventricular Leukomalacia
44. Hematopoietic Contribution to Skeletal Muscle Regeneration in Acid α-Glucosidase Knockout Mice
45. Antisense in vivo knockdown of synaptotagmin I by HVJ–liposome mediated gene transfer attenuates ischemic brain damage in neonatal rats
46. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
47. Alternative psychosis and dysgraphia accompanied by forced normalization in a girl with occipital lobe epilepsy
48. Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity
49. The effects of hyperglycemia on ischemic cell change and reactive neuronal change in neonatal rat brain following transient forebrain ischemia
50. SERUM LEVELS OF MYCN AMPLIFICATION IN NEUROBLASTOMA WITH TUMOR-RELEASED DNA BY REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.